Mid-Year Report

POLICY ADVOCATES for GLAXOSMITHKLINE

Firm
Client
Income
$45,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 556/S. 1610: To ensure national security while promoting foreign investment and the creation and maintenance of jobs, to reform the process by which such investments are examined for any effect they may have on national security, to establish the Committee on Foreign Investment in the United States, and for other purposes. Track and monitor. HR 2900/ S.1082: To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. Track and monitor. Track and monitor industry issues. Monitor FDA issues. HR 3161/S. 1859: Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2008. Track and monitor. HR 2638/ S.1644: Making approps. for the Dept. of Homeland Security for the FY ending September 30, 2008. Track and monitor.

LobbyistCovered position, as disclosed
SCOTT HATCH N/A
JACK MARTIN N/A
LAIRD WALKER N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2900 (110th), S. 1644 (110th), S. 1859 (110th), H.R. 3161 (110th), H.R. 556 (110th), H.R. 2638 (110th), S. 1610 (110th), S. 1082 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.